GlassScriptPhysician profile
Daewoong Lee
NPI 1477909703
$6,849.54
in general payments reported to CMS, 2019-2025
14 companies · $578 in 2025
The $578 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $1,068 · 2021: $1,795 · 2022: $1,695 · 2023: $666 · 2024: $498 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $761 · Food and Beverage: $614 · Education: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $761.45 |
| Food and Beverage | $613.90 |
| Education | $366.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,644.66 | 2021-2022 | |
| Boston Scientific Corporation | $1,179.68 | 2020-2022 | |
| Medtronic USA, INC. | $830.15 | 2020 | |
| Medtronic, INC. | $656.59 | 2021-2023 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Nevro Corp. | $602.78 | 2020-2024 | Senza |
| Becton, Dickinson and Company | $550.00 | 2019 | |
| Globus Medical, INC. | $507.13 | 2025 | Vyrsa V1, Senza, Vyrsa V1 |
| Painteq LLC | $486.18 | 2023-2024 | Painteq |
| Abbott Laboratories | $145.84 | 2022-2025 | Proclaim |
| Si-Bone, INC. | $83.05 | 2021-2023 | |
| Stryker Corporation | $56.96 | 2021 | |
| Nalu Medical, INC. | $47.59 | 2021 | |
| Spr Therapeutics, INC | $39.35 | 2021 | |
| Crossroads Orthopedics, LLC | $19.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daewoong Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.